Tag: europe

VRURC T009 3-in-1 Qi2 mag charger for Apple. 25W fast charge, dual cooling, retractable cable. Pre-order 62% off til June 20, 2026. 2y warranty.

"Insect 2151" Challenges Teens to Reimagine the Future Through Insect-Inspired Innovation, Offering $180,000 in Scholarships and Inspiring the Next Generation of InnovatorsATLANTA, June 16,...

Nordot rebrands as Ekkow, expanding from syndication into global content infrastructure for rights-cleared distribution, licensing, data, and AI.

JAKARTA, Indonesia, June 16, 2026 /PRNewswire/ -- OMOWAY announced the delivery of the world's first batch of OMO-X motorcycles in Indonesia on June 15....

Next-generation semantic intelligence platform accelerates enterprise AI modernization by 3X while ensuring strict compliance for regulated industries.LONDON, June 16, 2026 /PRNewswire/ -- Onix today...

Launching a resort-wide "Wing Lei Bar & Friends" Special Edition, Wynn will unite over 50 global mixology and culinary visionaries from July 24 to 29MACAO,...

Claret Capital Partners is providing growth funding of €43m as part of Inventiva’s €130m debt financing, to support its lead asset through Phase 3.

Expanded collaboration includes new joint policing solutions in the UK and broader investments in enterprise modernisation worldwideLONDON, June 16, 2026 /PRNewswire/ -- Appian (NASDAQ:...

162 million 5G subscriptions added during the first quarter of 2026, bringing the total to 3.1 billionThe number of commercial differentiated connectivity service offerings...

AMSTERDAM, 16 juin 2026 (GLOBE NEWSWIRE) -- Le professeur Ahmad AbuSalah, titulaire d’un doctorat, directeur du Digital Innovation Hub au King Faisal Specialist Hospital & Research Centre (KFSH), présente le modèle de l’hôpital visant à créer un écosystème d’intelligence artificielle appliquée en radiologie lors du congrès HLTH Europe 2026, qui se tiendra du 15 au 18 juin à Amsterdam. Il met en avant la manière dont l’IA peut passer d’un besoin clinique à un impact mesurable grâce à une gouvernance responsable, à l’intégration des flux de travail et à une adoption centrée sur l’humain.

HONG KONG, June 16, 2026 /PRNewswire/ -- XTransfer, the world's leading B2B cross-border trade payment platform, is proud to announce that it has been...

SkinVision Pro connects AI-powered skin health assessments directly to medical practices, giving doctors structured information before the consultation begins. AMSTERDAM, June 16, 2026 /PRNewswire/...

REYKJAVIK, Iceland , June 16, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB) (“Alvotech” or the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the pricing of its previously announced underwritten public offering (the “Offering”) of 22,666,667 of its ordinary shares at an offering price of $3.75 per share. All ordinary shares to be sold in the Offering will be offered by Alvotech. The Offering is expected to close on or about June 17, 2026, subject to satisfaction of customary closing conditions. The Company has also granted the underwriters a 30-day option to purchase up to an additional 3,400,000 ordinary shares at the public offering price, less underwriting discounts and commissions. Before deducting the underwriting discounts and commissions and offering expenses, the Company expects to receive total gross proceeds of approximately $85 million from the Offering, or approximately $98 million if the underwriters exercise in full their option to purchase additional shares.

New collaboration provides framework between the Japan government and ItalyTOKYO, June 15, 2026 /PRNewswire/ -- Rapidus Corporation today announced that it signed a Memorandum of...